12/22/2006 | CV | Market Commentary: Pinnacle takes off on new Northwest deal; Red Hat climbs on stronger than expected quarter
|
12/21/2006 | CV | Market Commentary: Peabody dragged lower with stock; ExpressJet calm on stock downgrade; Manor Care, Ciena gain slightly
|
12/20/2006 | CV | Market Commentary: Entertainment Properties rises slightly on debut; Peabody slides further with sector; Ford rallies on upgrade
|
12/19/2006 | CV | Market Commentary: Harrah's higher on offer acceptance; Entertainment Properties fails to impress; Titan wakes up on new deal
|
12/18/2006 | CV | Market Commentary: Harrah's rises on new buyout talk; Peabody retreats on gas prices; Entertainment Properties launches deal
|
12/15/2006 | CV | Market Commentary: International Game reoffers, gains slightly on debut; Peabody, Tech Data start out flat; PNC sees no trades
|
12/14/2006 | CV | Market Commentary: Peabody upsizes, gains in gray; Cadence rises; International Game to reoffer; PNC, Tech Data launch deals
|
12/13/2006 | CV | Market Commentary: Continental, UAL float on merger speculation; Cooper Cos. falls outright on results; Cadence quiet in gray
|
12/12/2006 | CV | Market Commentary: ON lights up on debut; Beckman Coulter gains on cheap pricing; Acquicor rises; Cadence launches deal
|
12/11/2006 | CV | Market Commentary: Continental, UAL climb on merger speculation; Beckman Coulter quiet as talk cheapened; ON plans deal
|
12/8/2006 | CV | Market Commentary: Orbital soars on launch; Superior Energy sees small gain; Prudential modest on debut; Ford stays buoyant
|
12/7/2006 | CV | Market Commentary: Ford drives market into frenzy; MannKind leaps ahead; Superior Energy flat in gray; Prudential plans deal
|
12/6/2006 | CV | Market Commentary: Ford climbs further on upsize, new talk; First Potomac, Acadia flat on debuts; Superior Energy plans deal
|
12/5/2006 | CV | Market Commentary: Ford deal surges in the gray; Acadia bid higher in pre-market; First Potomac upsizes, prices offering
|
12/4/2006 | CV | Market Commentary: LSI Logic drops, Agere climbs on merger; Reckson mum on new offer; Bunge gains; Ford unveils deal
|
12/1/2006 | CV | Market Commentary: JDS Uniphase firm on sector concerns; Goodrich quiet in debut; Amgen, Gilead hit on broad pullback
|
11/30/2006 | CV | Market Commentary: Sirius gains on new product; Level 3 higher on rumors; Goodrich plans deal; Acquicor seen as outright deal
|
11/29/2006 | CV | Market Commentary: AGCO gains on first day; Transmeridian upsized, locked away on debut; Advanced Medical slightly better
|
11/28/2006 | CV | Market Commentary: Ventas flat on debut; AGCO higher in gray; MannKind quiet as stock borrow a concern
|
11/27/2006 | CV | Market Commentary: Ford stalls on financing plans; Scottish Re climbs on liquidity boost; Ventas gains in gray as deal reoffered
|
11/22/2006 | CV | Market Commentary: Equity Office gains slightly; Medtronic unchanged after rally; Acquicor set price talk
|
11/21/2006 | CV | Market Commentary: Advanced Medical falls on recall; Medtronic climbs on results; Continental gains on merger hopes
|
11/20/2006 | CV | Market Commentary: Equity Office rallies on buyout; REITs climb on consolidation speculation; Freeport-McMoran up on deal
|
11/17/2006 | CV | Market Commentary: RARE, School Specialty climb on debut; Duke opens flat; Chattem stays out of sight; Euroseas plans offer
|
11/16/2006 | CV | Market Commentary: China Medical climbs on debut; RARE up, Duke, School Specialty, Chattem quiet in gray; Interpublic rises
|
11/15/2006 | CV | Market Commentary: Bunge gains, Vornado flat, Health Care quiet on debuts; JetBlue, UAL rise on U.S. Airways-Delta deal
|
11/14/2006 | CV | Market Commentary: Earthlink, EMC, deCODE rise; Bunge climbs on new talk; Health Care, China Medical face tough borrow
|
11/13/2006 | CV | Market Commentary: EMC, Earthlink gain in gray; UAL cracks on LBO rumors; Bunge, Health Care REIT lead issuance surge
|
11/10/2006 | CV | Market Commentary: General Cable, upsized Millennium climb on trading debuts; Medis locked up; Disney slides on results
|
11/9/2006 | CV | Market Commentary: SanDisk higher on rumors; Amkor jumps following results; General Cable up, Millennium silent in gray
|
11/8/2006 | CV | Market Commentary: Hornbeck, Inland's upsized deals climb on debut; Novell gains on pact's payoff; General Cable plans deal
|
11/7/2006 | CV | Market Commentary: Arris deal climbs on debut; Hornbeck bid up, Inland silent in the gray; JetBlue rises on upgrade
|
11/6/2006 | CV | Market Commentary: Four Seasons springs up on buyout; XM climbs on results, buoys Sirius; Arris silent in gray
|
11/3/2006 | CV | Market Commentary: CA falls on forecast; NRG climbs on guidance, new hedge; Medis delays deal; Six Flags higher on outlook
|
11/2/2006 | CV | Market Commentary: Pier 1 lower on weak sales; Red Hat holds on Novell-Microsoft deal; Medical Properties, Medis deals quiet
|
11/1/2006 | CV | Market Commentary: Charter Communications, Ceradyne climb on results; Core rises on debut; Medical Properties gains in gray
|
10/31/2006 | CV | Market Commentary: Omnicare improves hedged on results; Core Labs offered higher in gray; Medical Properties plans deal
|
10/30/2006 | CV | Market Commentary: Level 3 gains on takeout rumors; Medis quiet amid borrow concerns; Invitrogen, Red Hat gain slightly
|
10/27/2006 | CV | Market Commentary: Wesco gains, Kemet quiet on debut; FiberTower keeps rising; Red Hat higher on buyback; Invitrogen slips
|
10/26/2006 | CV | Market Commentary: FiberTower soars on debut; Red Hat better hedged on Oracle rivalry; Kemet, Wesco higher in the gray
|
10/25/2006 | CV | Market Commentary: ImClone slips on board change; Mills gains on offer; United Therapeutics improves; GM slips
|
10/24/2006 | CV | Market Commentary: JetBlue climbs on trimmed expansion; Lucent gains on results; United Therapeutics prices deal; L-3 slips
|
10/23/2006 | CV | Market Commentary: Connetics soars on buyout; Ford slips; FiberTower could see tough borrow; United Therapeutics plans deal
|
10/20/2006 | CV | Market Commentary: SanDisk, Informatica crumble on guidance; Synaptics gains on results; Continental climbs on upgrade
|
10/19/2006 | CV | Market Commentary: Cypress falls on dashed hopes; Barnes climbs on results; Minefinders strikes gold; Home Properties gains
|
10/18/2006 | CV | Market Commentary: St. Jude flat, drags Medtronic lower; AMR gains on profit; Home Properties, Minefinders quiet in the gray
|
10/17/2006 | CV | Market Commentary: Level 3 jumps, Broadwing trips on buyout; ICOS gains on Eli Lilly offer; Home Properties launches deal
|
10/16/2006 | CV | Market Commentary: Open Solutions soars on buyout; Bausch and Lomb, Wyeth slip on rate fears; SanDisk gains on outlook
|
10/13/2006 | CV | Market Commentary: Five Star shoots up on debut; American Express garners interest as reset nears; Red Hat falls on rumors
|
10/12/2006 | CV | Market Commentary: Amkor rises with upgrade; ExpressJet, JetBlue climb on new confidence; Five Star shines in the gray
|
10/11/2006 | CV | Market Commentary: DOV gains on delisting speculation; Nabors slips amid buyout rumors; Harrah's lower with stock
|
10/10/2006 | CV | Market Commentary: Nabors gains on buyout rumors; ImClone flat; Amkor climbs with credit; Priceline.com gains on tender
|
10/9/2006 | CV | Market Commentary: Amkor splits ways with defaults cured; New River quiet despite drug OK; General Motors gains with stock
|
10/6/2006 | CV | Market Commentary: LeCroy, Diodes gain after rich pricing; HRPT, United Dominion improve; Cypress rises on buyout hopes
|
10/5/2006 | CV | Market Commentary: Forest City gains modestly on debut; HRPT upsizes deal; United Dominion prices; Human Genome climbs
|
10/4/2006 | CV | Market Commentary: ImClone higher on buyout talk; World Acceptance jumps on debut; Ford gains, GM slips on ceased talks
|
10/3/2006 | CV | Market Commentary: World Acceptance richens talk; LeCroy flat in the gray; Pier 1 gains on dividend cut; Forest City plans deal
|
10/2/2006 | CV | Market Commentary: Harrah's offer cuts into hedges; Gilead slips outright on Myogen acquisition; World Acceptance plans deal
|
9/29/2006 | CV | Market Commentary: Brandywine lackluster on debut; Amkor reactions mixed to revised offer; Ford gains slightly
|
9/28/2006 | CV | Market Commentary: Amkor up on revised offer; Nabi gains on sale hopes; ImClone rides stock rally; Brandywine quiet in gray
|
9/27/2006 | CV | Market Commentary: BearingPoint, Amkor slip on default woes; Red Hat falls outright with earnings; Brandywine plans deal
|
9/26/2006 | CV | Market Commentary: Advanced Medical, PMC-Sierra falls on warnings; Cephalon gains on drug nod; ChipMOS prices
|
9/25/2006 | CV | Market Commentary: Sandisk slips on downgrade; Equity Residential, National Retail gain on rate play; Charles River up on vol
|
9/22/2006 | CV | Market Commentary: Priceline climbs on debut; Lions Gate jumps on stock upgrade; Novell steady amid looming default
|
9/21/2006 | CV | Market Commentary: Incyte's new notes rise as old paper crumples; Priceline deal seen as rich; Novell gains on default potential
|
9/20/2006 | CV | Market Commentary: First Industrial, BioMed higher on debuts; XM gains further; Red Hat climbs with stock; Incyte plans deal
|
9/19/2006 | CV | Market Commentary: ImClone slips on lost patent; Yahoo drops with sales warning; First Industrial, BioMed launch REIT deals
|
9/18/2006 | CV | Market Commentary: XM Satellite maintains climb; Commonwealth climbs on takeover; Human Genome keeps tightening
|
9/15/2006 | CV | Market Commentary: U.S. Bancorp sees lackluster debut; Ford lower on new cuts; General Motors retreats on sector woes
|
9/14/2006 | CV | Market Commentary: PolyMedica surges, Bristow gains, New Plan flat on debuts; XM rises on upgrade, U.S. Bancorp plans deal
|
9/13/2006 | CV | Market Commentary: Triumph, AmeriCredit gain, Corporate Office flat; PolyMedica, Bristow up in the gray; New Plan prices
|
9/12/2006 | CV | Market Commentary: Best Buy, Ford gain; Corporate Office prices; AmeriCredit sets talk; New Plan, Polymedica launch deals
|
9/11/2006 | CV | Market Commentary: Scottish Re gains on buyout bids; ImClone rallies with stock; AmeriCredit, Bristow lead wave of new deals
|
9/8/2006 | CV | Market Commentary: National Retail gains on debut; Cell Genesys takes comfort in stock sale; AirTran dives on lowered outlook
|
9/8/2006 | CV | Calyon plans three reverse convertible offerings; HSBC plans 30% reverse convertibles linked to Rambus
|
9/7/2006 | CV | Market Commentary: Alliant up on debut; National Retail deal panned; Lucent gains on deal nod; Beazer better for hedges
|
9/6/2006 | CV | Market Commentary: Washington deal opens flat; Alliant deal bid up in gray; OMI dragged by oil; Komag shrugs off cut forecast
|
9/5/2006 | CV | Market Commentary: Intel slips before cuts; Viacom down on CEO reshuffle; Ford shrugs off reports; Washington launches deal
|
9/1/2006 | CV | Market Commentary: Intel gains on possible job cuts; Gateway slips on spurned offer; General Motors climbs, Ford falls on sales
|
8/31/2006 | CV | Market Commentary: Valassis improves on attempt to end deal; JDSU falls with poor guidance; CompuCredit rides stock rally
|
8/30/2006 | CV | Market Commentary: Novell gains on internal options probe; ADC slips on lowered forecast; Costco down on poor outlook
|
8/29/2006 | CV | Market Commentary: L-3 gains on reports; Equity Residential eases from climb; Intel higher on new chips; Headwaters flat
|
8/28/2006 | CV | Market Commentary: Red Hat slips on stock downgrade; Lucent declines on deal resistance; Continental gains as oil falls
|
8/28/2006 | CV | Morgan Stanley prices notes linked to S&P; UBS plans seasonal variable-exposure notes
|
8/25/2006 | CV | Market Commentary: Ford gains on deal speculation; Tanger gains on REIT sentiment; Lucent, Medtronic unchanged
|
8/24/2006 | CV | Market Commentary: REIT convertibles gain on volatility; Lucent gains on report, support for merger; Casual Male corrects
|
8/23/2006 | CV | Market Commentary: Gateway climbs on offer; Developers REIT deal falls flat; Cell leaps on trial data; Ford picks up speed
|
8/22/2006 | CV | Market Commentary: Mills higher on project financing deal; Developers REIT offer draws poor reviews; Scottish Re widens
|
8/21/2006 | CV | Market Commentary: Ford keeps sliding; Lowe's slips on poor outlook; Armor firms on reports; Bristow deal won't price so soon
|
8/18/2006 | CV | Market Commentary: Ford slips on cuts; Macrovision lights up debut; Scottish Re shrugs off rumors; Bristow plans deal
|
8/17/2006 | CV | Market Commentary: Equity Residential starts higher; Macrovision ups deal amid strong gray market; PMC-Sierra up on filings
|
8/17/2006 | CV | Morgan Stanley plans portfolio trigger securities offering; Rabo plans slate of knock-in reverse convertibles
|
8/16/2006 | CV | Market Commentary: Itron climbs on sentiment, acquisition; Ford, Intel, Symantec ride equity rally; Equity REIT quiet in gray
|
8/15/2006 | CV | Market Commentary: CA up on restructuring, stock buyback; Calgon gains amid borrow concerns; Equity Residential plans deal
|
8/15/2006 | CV | JPMorgan plans 30% reverse exchangeables offering; emerging markets-linked deals are hot, insider says
|
8/14/2006 | CV | Market Commentary: CV Therapeutics gets hit; Ford gains on upgrade; Calgon borrow uncertain; Tanger climbs further
|
8/11/2006 | CV | Market Commentary: Charter climbs on exchange offer; Tanger shines, Retail Ventures/DSW quiet on debuts; Andrew stays firm
|
8/10/2006 | CV | Market Commentary: Andrew, ImClone fall on failed buyouts; BRE, Digital Realty climb on debuts; Cephalon firm as drug flops
|
8/9/2006 | CV | Market Commentary: BRE, Digital Realty bright in the gray; Amkor mixed on delayed filing; Tanger, Retail Ventures plan deals
|
8/9/2006 | CV | Merrill prices three substantial return notes offerings; Barclays offers slate of exchangeable notes
|
8/8/2006 | CV | Market Commentary: McData gains with offer; Teva rides earnings boost; Scottish Re firms as put stays; Charter slips on loss
|
8/7/2006 | CV | Market Commentary: Scottish Re rides stock upgrade, but confusion persists on put; Andrew approaches par on CommScope bid
|
8/7/2006 | CV | HSBC kicks off registered note program; JPMorgan to price two return-enhanced notes
|
8/4/2006 | CV | Market Commentary: Scottish Re stays high; Reckson rides counter-bid rumors; Invitrogen shrugs off miss; PDL gains in line
|
8/3/2006 | CV | Market Commentary: Medtronic, DRS fall outright on poor guidance; Transocean slides on miss; CompuCredit declines
|
8/2/2006 | CV | Market Commentary: Ford revs up on new advisor; Medtronic, St. Jude gain on Medicare changes; Huntsman gets results boost
|
8/1/2006 | CV | Market Commentary: Kodak holds against outlook; Scottish Re calms nerves; Itron gains off the blocks; GM declines
|
7/31/2006 | CV | Principal-protected products the way to go, structurer says; July volume was hot, August may cool off
|
7/31/2006 | CV | Market Commentary: Scottish Re hit by put worries; Cephalon swings; SanDisk flat, M-Systems gains on deal; Itron solid in gray
|
7/28/2006 | CV | Market Commentary: Conexant slips after loss; Weingarten flat on debut; Inco gains on failed bid; results dampen second half
|
7/27/2006 | CV | Market Commentary: Omnicare withstands profit cut; Symantec rises with results; XM unmoved by loss; Weingarten plans deal
|
7/26/2006 | CV | Market Commentary: General Motors earnings drives rally; Amazon.com withstands profit drop; Mercury warms up; UAL mixed
|
7/25/2006 | CV | Market Commentary: SanDisk jumps with strong earnings; Amylin in line after notes called; UAL prices $726 million deal
|
7/24/2006 | CV | Market Commentary: Amazon.com better ahead of results; ImClone gains on buyout hopes; Amylin drops as call hurdle topples
|
7/21/2006 | CV | Market Commentary: Amgen climbs with earnings; Halliburton, Schlumberger slip outright; PMC-Sierra tumbles on loss
|
7/20/2006 | CV | Market Commentary: Intel, Ford, Barnes fall on earnings weakness; New River quiet on debut; Essex plans $130 million deal
|
7/19/2006 | CV | Market Commentary: Yahoo! stumbles on product delay; airlines better on earnings; New River's poor borrow hampers deal
|
7/18/2006 | CV | Market Commentary: Avnet improves on Lehman recommendation; Sanmina-SCI unmoved by warning; New River plans deal
|
7/17/2006 | CV | Market Commentary: Nabors falls with oil prices; Electronics for Imaging brightens with upgrade; Lucent still weak on forecasts
|
7/14/2006 | CV | Market Commentary: Ford slides as story sputters; GM weaker; deCODE Genetics widens; Teva steady despite loss to Forest
|
7/13/2006 | CV | Market Commentary: Intel shrugs off layoffs; SanDisk retreats on expansion plans; General Motors mixed before meeting
|
7/12/2006 | CV | Market Commentary: Genzyme, AAR jump outright with earnings; Archstone-Smith slows; Health Management gains further
|
7/11/2006 | CV | Market Commentary: Archstone-Smith's reoffered deal gains on debut; Connetics steady on stock rebound; SanDisk recovers
|
7/10/2006 | CV | Market Commentary: SanDisk gains on speculation; Gilead improves ahead of results; Archstone-Smith plans overnight deal
|
7/7/2006 | CV | Market Commentary: PMC-Sierra trips on outlook, CFO's resignation; General Motors up on meeting; Par Pharmaceutical eases
|
7/6/2006 | CV | Market Commentary: Par Pharmaceutical gains amid restatements; Openwave slips on weak forecast; tech names better bid
|
7/5/2006 | CV | Market Commentary: General Motors mixed on alliance talk; American Express slides; Health Management confirms new yield
|
7/3/2006 | CV | Market Commentary: Health Management continues to gain on sweetener; General Motors slides amid alliance talks
|
6/30/2006 | CV | Market Commentary: Cephalon climbs on drug's progress; General Motors gains with stock; Health Management gets sweeter
|
6/29/2006 | CV | Market Commentary: Red Hat rises dollar-neutral, falls outright; new Vector bid higher; CNET, Intel gain; Nexans prices deal
|
6/28/2006 | CV | Market Commentary: New issues of Vector Group, Chesapeake Energy rise; overall market wavers
|
6/27/2006 | CV | Market Commentary: MedImmune, Gilead trade; Vector launches overnight deal; Chesapeake prices
|
6/26/2006 | CV | Market Commentary: Intel, Amgen under pressure; Inco rises; Chesapeake launches mandatories offering
|
6/23/2006 | CV | Market Commentary: Convertibles mostly quiet; Six Flags drops outright, new MedImmune issues lifted 1 point
|
6/22/2006 | CV | Market Commentary: MedImmune on deck, no gray seen; Equity Office Properties, American Medical new deals seen higher
|
6/21/2006 | CV | Market Commentary: Teva sinks outright, holds up dollar neutral; Group 1 re-offered; $2 billion new deals seen pricing Thursday
|
6/20/2006 | CV | Market Commentary: Medtronic, Amgen fall prey to selling pressure; JetBlue adds; Actuant plunges
|
6/19/2006 | CV | Market Commentary: Red Hat, Symantec trade actively; Carnival gains; Group 1, American Medical launch new issues
|
6/16/2006 | CV | Market Commentary: Guitar Center trades to call; Carnival gains after guidance, stock buyback plan; Symmetricom falls outright
|
6/15/2006 | CV | Market Commentary: Omnicare, Encysive climb on positive regulatory news; SanDisk gains on upgrade; Synaptics up in line
|
6/14/2006 | CV | Market Commentary: Intel gains on stock upgrade; Alleghany seen slightly cheap; Freeport-McMoran rises with copper prices
|
6/13/2006 | CV | Market Commentary: Advanced Medical, Charles River, Nabors gain on volatility; Symantec flat on debut; Nektar drops outright
|
6/12/2006 | CV | Market Commentary: Symantec reoffers, prices deal at cheap end of talk; NPS unmoved by restructuring; Comverse slides
|
6/9/2006 | CV | Market Commentary: Advanced Medical brushes off Fitch downgrade; Gilead, Amgen, Trinity gain; L-3 unchanged
|
6/8/2006 | CV | Market Commentary: Level 3, Advanced Medical climb on arrival; International Rectifier scraps deal; Interpublic stays aloft
|
6/7/2006 | CV | Market Commentary: Interpublic, Spansion, Charles River climb, Millipore struggles on debuts; Level 3 up in gray; L-3 gains
|
6/6/2006 | CV | Market Commentary: New deals seen as unexciting; Spansion structure seen as too long; Charles River, Millipore views mixed
|
6/5/2006 | CV | Market Commentary: SanDisk gains outright on stock upgrade; Sepracor falls on probe; Interpublic plans unique deal
|
6/2/2006 | CV | Market Commentary: Trinity gains on debut; Novell improves further on volatility, takeover speculation; Encysive gains outright
|
6/1/2006 | CV | Market Commentary: Cubist stacks up well on debut; Novell holds up against weak guidance; Trinity gains in the gray
|
5/31/2006 | CV | Market Commentary: Cubist climbs in gray market; L-3 improves on stock downgrade; Novell seen to firm on poor guidance
|
5/30/2006 | CV | Market Commentary: CA up dollar-neutral amid delayed earnings; Level 3 deal seen as attractive; Cubist plans deal as expected
|
5/26/2006 | CV | Market Commentary: Credence firm despite downgrades; Cubist gains on FDA approval; Nabors, Transocean up with stocks
|
5/25/2006 | CV | Market Commentary: Encysive gains outright on FDA submission; Omnicare, XM Satellite better on hedge amid stock declines
|
5/24/2006 | CV | Market Commentary: Global Crossing, CBIZ gain in line on debuts; Midway sees narrow interest; Medtronic gets results boost
|
5/23/2006 | CV | Market Commentary: Cameron debut hurt by premium; Global Crossing deal sees poor borrow; CBIZ prices offer within talk
|
5/22/2006 | CV | Market Commentary: Transocean, Oil States slide on oil concerns; Amgen gains on upgrade; Cameron premium meets resistance
|
5/19/2006 | CV | Market Commentary: SafeNet improves dollar-neutral on federal probe; American Axle likely to be converted, analyst says
|
5/18/2006 | CV | Market Commentary: Enzon climbs, Nabors flat on debuts; American Axle gains on conversion expectations; DOV slides further
|
5/17/2006 | CV | Market Commentary: American Axle continues rally on conversion option; Greenbrier up on debut; Enzon deal seen as decent
|
5/16/2006 | CV | Market Commentary: American Axle surges on possible loophole; DOV Pharmaceuticals falls, Sepracor gains on drug's rejection
|
5/15/2006 | CV | Market Commentary: Bausch and Lomb gains on product recall; FEI prices $100 million deal within talk
|
5/12/2006 | CV | Market Commentary: Amkor, Manor Care gain on debuts; JDS Uniphase pulled down by stock; Global Crossing plans deal
|
5/11/2006 | CV | Market Commentary: Amkor, JDS Uniphase, Manor Care gain in gray; Scottish Re improves on stock rebound; Merix prices deal
|
5/10/2006 | CV | Market Commentary: SanDisk, Broadwing climb on debuts; Amkor, JDS Uniphase, Manor Care plan deals; Teva steady on loss
|
5/9/2006 | CV | Market Commentary: SanDisk deal gains in gray market; Broadwing offering seen as fair; General Motors mixed on upgrade
|
5/8/2006 | CV | Market Commentary: Fisher Scientific, Emmis climb on merger, acquisitions; Silicon Graphics takes beating on Chapter 11 filing
|
5/5/2006 | CV | Market Commentary: Safenet gains on earnings, stock buyback; Scottish Re widens after poor quarter; Finisar flat after rally
|
5/4/2006 | CV | Market Commentary: Bausch and Lomb up dollar-neutral on debt tenders; JDS Uniphase falls outright on poor guidance
|
5/3/2006 | CV | Market Commentary: Cephalon falls, PDL widens on results; NPS falls, MGI climbs on FDA news; XM firm despite lawsuits
|
5/2/2006 | CV | Market Commentary: Apex Silver falls on Bolivia concerns; Quicksilver gains on earnings anticipation; Sirius up on guidance
|
5/1/2006 | CV | Market Commentary: Level 3 gains on $1.2 billion acquisition; Teva gets court boost; Human Genome tightens on drug trials
|
4/28/2006 | CV | Market Commentary: Quanta reoffers $125 million deal half a point below talk at 97.75; Skechers sees interest as maturity nears
|
4/27/2006 | CV | Market Commentary: XM Satellite slides on earnings; Quanta delays $125 million offering; Vitesse falls on restatements
|
4/26/2006 | CV | Market Commentary: General Motors' gains boost auto sector; Flextronics up on rival's earnings; Quanta plans $125 million deal
|
4/25/2006 | CV | Market Commentary: Serologicals weakens on hedged basis; JetBlue, Level 3 gain on results; Dov falls on drug trial woes
|
4/24/2006 | CV | Market Commentary: Bausch and Lomb, Schlumberger get analysts' thumbs up; Halliburton, Medtronic shrug off reports
|
4/21/2006 | CV | Market Commentary: Mercury Interactive gains on waiver consent offer; Vitesse marked lower on delayed filings
|
4/20/2006 | CV | Market Commentary: General Motors gains, Intel falls on quarterly results; Gilead new deal stumbles on debut;
|
4/19/2006 | CV | Market Commentary: ExpressJet stands firm on lost business; Gilead deal priced cheaper than talk; Cephalon gains on new data
|
4/18/2006 | CV | Market Commentary: Freeport-McMoran surges on strong earnings; JDS Uniphase rebounds; Gilead plans $1.1 billion deal
|
4/17/2006 | CV | Market Commentary: Delta, JetBlue dive on oil, downgrades; Red Hat falls, Novell gains on Oracle CEO's comments
|
4/13/2006 | CV | Market Commentary: Medtronic gains dollar-neutral on debut; Bausch and Lomb rebounds before product pulled
|
4/12/2006 | CV | Market Commentary: Bausch and Lomb firms against falling stock; Cypress rebounds as Synaptics flattens; Rentech debut quiet
|
4/11/2006 | CV | Market Commentary: Bausch and Lomb wider on product scare; Synaptics gains on iPod rumors; Medtronic plans $4 billion deal
|
4/10/2006 | CV | Market Commentary: Red Hat gains 8 points outright on acquisition; Oscient keeps sliding; Rentech deal sees poor interest
|
4/7/2006 | CV | Market Commentary: Safenet convertibles gain against stock crash; Allergan falls on debut; Rentech sets talk on new deal
|
4/6/2006 | CV | Market Commentary: Allergan new deal stumbles in the gray; Annaly offering seen as hedge play; Cell Therapeutics plans deal
|
4/5/2006 | CV | Market Commentary: Conexant gains on report; ON Semiconductor up despite downgrade; Ciena struggles off the blocks
|
4/4/2006 | CV | Market Commentary: Ciena's upsized $300 million deal up in gray market; American Equity higher; Symmetricom falls
|
4/3/2006 | CV | Market Commentary: Lucent up on Alcatel merger; General Motors' 4.5% convertible gains on GMAC sale
|
3/31/2006 | CV | Market Commentary: Boston Properties deal prices at cheap end of talk; ExpressJet improves; quarter's end spurs activity
|
3/30/2006 | CV | Market Commentary: BioMarin, Best Buy, Lamar Advertising gain; but Casual Male, Level 3, Interpublic are lower
|
3/29/2006 | CV | Market Commentary: Lear gains on financing news, Amdocs strengthens; new issue from AMG fails to enthuse
|
3/28/2006 | CV | Market Commentary: Level 3, Time Warner Telecom, Transocean gain on stronger outlooks; Affiliated Managers plans new deal
|
3/27/2006 | CV | Market Commentary: Lucent preferreds climb on hopes of post-merger tender; Time Warner Telecom stock upgrade boost
|
3/24/2006 | CV | Market Commentary: Cephalon setback positive for hedged players; Lucent strengthens on merger talks; BioMarin starts strong
|
3/23/2006 | CV | Market Commentary: BioMarin new deal gets thumbs-up; YRC weaker on poor outlook; Cephalon fails to get FDA nod
|
3/22/2006 | CV | Market Commentary: General Motors rises on union deal; Cephalon see-saws on drug prospects; Interpublic cut by S&P
|
3/21/2006 | CV | Market Commentary: BioMarin comes in ahead of new issue; Casual Male seen as cheap; Vista delay could mean tech troubles
|
3/20/2006 | CV | Market Commentary: Kerzner buyout hurts hedge investors; BioMarin plans new deal; Time Warner Telecom offer seen as cheap
|
3/17/2006 | CV | Market Commentary: General Motors falls in line with stock; Time Warner Telecom plans $200 million deal;
|
3/16/2006 | CV | Market Commentary: BioMarin stock hovers near strike price with call approaching; Kulicke and Soffa raises chip sector worries
|
3/15/2006 | CV | Market Commentary: Waste Connections gains on debut; Universal ups premium in talk; CSX, PMC-Sierra gain on upgrades
|
3/14/2006 | CV | Market Commentary: Fair Isaac plunges on fears of new rival product; Human Genome slides on mixed trial results
|
3/13/2006 | CV | Market Commentary: Lear surges on rumored refinancing; Apex Silver slides on probe; Watson falls on takeover
|
3/10/2006 | CV | Market Commentary: Nortel holds firm on cross-default hopes; American Axle survives downgrade but JetBlue crashes
|
3/9/2006 | CV | Market Commentary: General Motors get boost from rumors of union deal; Transocean, Amgen stronger; MOL to launch deal
|
3/8/2006 | CV | Market Commentary: Informatica's surprise issue, Coherent up on debuts; Albany International's new deal struggles
|
3/7/2006 | CV | Market Commentary: Coherent, Albany new deals seen as unexciting by analysts; Novell falls with stock; NRG Energy rebounds
|
3/6/2006 | CV | Market Commentary: Coherent, Albany International launch new deals; Teva, General Motors gain on positive news
|
3/3/2006 | CV | Market Commentary: Intel holds up on hedged basis despite stock slide; Citigroup says convertible arbitrage paid off in February
|
3/2/2006 | CV | Market Commentary: Conexant, ArvinMeritor debuts lukewarm; auto plays beaten down; Huntsman under credit review
|
3/1/2006 | CV | Market Commentary: HealthSouth, ArvinMeritor deals get warm reception; Woodson says convertibles making comeback
|
2/28/2006 | CV | Market Commentary: Mentor Graphics up on debut; Citadel down on challenge by bondholders; ArvinMeritor to price new deal
|
2/27/2006 | CV | Market Commentary: HealthSouth up half point in gray; Mentor Graphics deal talked at 5.75%-6.25%, up 60%-70%
|
2/24/2006 | CV | Market Commentary: Navistar 4.75% gains two points on cash tender offer; American Tower gains with stock
|
2/23/2006 | CV | Market Commentary: Apex Silver, Fannie Mae, EDO gain; Freeport, Greatbatch dip; HealthSouth to price $300 million
|
2/22/2006 | CV | Market Commentary: MeriStar dives on buyout news; QLT gains despite wider losses; Amgen strong
|
2/21/2006 | CV | Market Commentary: Citadel driven up on rumors; General Motors fall on Moody's downgrade; Meristar deal could hurt bonds
|
2/17/2006 | CV | Market Commentary: Citadel gains on rumors of put-seeking hedge funds; Amgen's new issues continue week's climb
|
2/16/2006 | CV | Market Commentary: Amgen convertibles active in trade; Halliburton gains; XM Satellite lower
|
2/15/2006 | CV | Market Commentary: New Amgen convertibles lift in active trade; Cephalon rises on guidance, Delta Air Lines weakens
|
2/14/2006 | CV | Market Commentary: Amgen prices upsized $5 billion issue; Transocean takes a dive on flat outlook; Akela Capital calls it quits
|
2/13/2006 | CV | Market Commentary: Oil and gas plays Chesapeake, Nabors fall on lower oil prices; all eyes on Amgen, GM in week ahead
|
2/10/2006 | CV | Market Commentary: Freeport-McMoran, Inco sink in metals meltdown; Level 3 gains while investors still sweet on Nektar
|
2/9/2006 | CV | Market Commentary: New Pier 1 issue jumps; GrafTech drops, but Best Buy gains on guidance; XM Satellite lifts
|
2/8/2006 | CV | Market Commentary: Citadel retraces some gains; Qwest flat but adds on hedge; MGI better; Oil States lower; Pier 1 prices
|
2/7/2006 | CV | Market Commentary: GM, Nabors slide despite positive news; Citadel gains from speculation; Pier 1 to price new deal
|
2/6/2006 | CV | Market Commentary: Huntsman converts fall as sale dropped; Transocean rises on new contracts; JetBlue slides on worries
|
2/3/2006 | CV | Market Commentary: UBS AG sets record with $2 billion of 18-month exchangeables; Amazon.com converts hold steady
|
2/2/2006 | CV | Market Commentary: ImClone steady despite lack of Bristol-Myers interest; Teva under pressure; Omnicare edges lower
|
2/1/2006 | CV | Market Commentary: JetBlue, Pixelworks down on earnings, but Cymer up; Schlumberger drops
|
1/31/2006 | CV | Market Commentary: Earnings send Sepracor higher, but UnumProvident, Goodyear lower; Huntsman adds on takeout talk
|
1/30/2006 | CV | Market Commentary: Omnicare converts plunge on raid news; new DRS issue slows down; GMAC bids lift GM
|
1/27/2006 | CV | Market Commentary: Deals from Teva, AAR draw attention to new issues; Nektar in play on product rumors; GM up
|
1/26/2006 | CV | Market Commentary: New issues mixed, NRG trades up, UAG flat; Juniper drops; DRS launches $300 million of convertibles
|
1/25/2006 | CV | Market Commentary: Cracker Barrel, Calpine gain; Charter edges lower; Teva, AAR launch convertible deals
|
1/24/2006 | CV | Market Commentary: ImClone convertibles jump on potential sale; focus shifts to proposed NRG, UAG deals
|
1/23/2006 | CV | Market Commentary: Albertson's, Dick's trade on acquisition news; United Auto launches $250 million deal
|
1/20/2006 | CV | Market Commentary: Hutchinson hovers around par; Schlumberger surges; Ford sags, Oscient tumbles
|
1/19/2006 | CV | Market Commentary: Advanced Micro, Cypress gain, but Intel weaker; Hutchinson prices upsized $225 million deal
|
1/18/2006 | CV | Market Commentary: Techs dominate convertibles market; Intel drops outright but expands on a hedged basis, AMD adds
|
1/17/2006 | CV | Market Commentary: Convertibles move mostly lower as oil gains; Tyco, airlines drop, but Schlumberger adds
|
1/13/2006 | CV | Market Commentary: Tyco moves lower on lower guidance, break-up plan; Lucent mixed; Wyeth up
|
1/12/2006 | CV | Market Commentary: Convertibles market turns mostly lower; biotechs, autos, oil services down, but Six Flags gains
|
1/11/2006 | CV | Market Commentary: Convertibles market remains mixed; Intel weaker; Connetics, Ford better
|
1/10/2006 | CV | Market Commentary: LifePoint Hospitals, MGI Pharma convertibles weaker on lower guidance; Cephalon jumps; GM mixed
|
1/9/2006 | CV | Market Commentary: Convertibles market extends gains; Human Genome, GM, Delta Air Lines, Duke up
|
1/6/2006 | CV | Market Commentary: Convertibles market moves mostly in-line, dollar neutral; Best Buy, Cephalon gain; Affymetrix drops
|
1/5/2006 | CV | Market Commentary: Convertible market extends broad-based gains; autos, biotechs lift; Fannie Mae adds
|
1/4/2006 | CV | Market Commentary: Convertible market sees broad-based gains, GM, Ford lift; airlines better, Calpine adds points
|
1/3/2006 | CV | Market Commentary: Wyeth convertibles up on pact; Cephalon adds; Mercury Interactive mostly flat
|